<DOC>
	<DOCNO>NCT01852786</DOCNO>
	<brief_summary>The aim- To evaluate impact combine oral contraceptive woman 's psychosexual , metabolic , blood coagulation , hormonal genetic measure . Combined oral contraceptive ( COCs ) still popular contraception method . It possible find number publication non-contraceptive benefit , also adverse event . Most research conduct clinical trial , commission pharmaceutical company , order compare COCs different composition . This study set assess role psychosexual , metabolic , endocrine , hormonal genetic measure low dose combine oral contraceptive users- 20 microgram Ethinylestradiol/3 mg Drospirenone 20 microgram Ethinylestradiol/75 microgram Gestoden . Because study commercial , expect obtain valuable objective data - comparative study impact COCs woman 's organism .</brief_summary>
	<brief_title>The Effect Hormonal Contraception Female</brief_title>
	<detailed_description>The aim To evaluate impact combine oral contraceptive woman 's psychosexual , metabolic , blood coagulation , hormonal genetic measure . The objective 1 . To asses relation AR polymorphisms metabolic , androgen , blood coagulation parameter sexual function hormonal contraceptive user . 2 . To compare change metabolic , coagulation endocrine parameter hormonal non-hormonal contraceptive user . 3 . To assess impact COCs quality woman 's sexual life psychological state . 4 . To assess correlation sex hormone woman 's metabolic , endocrine , psychological , sexual function . 5 . To evaluate influence COCs blood coagulation parameter . 6 . To determine importance androgen parameter diagnosis hyperandrogenism . Materials Methods Setting׃ The study conduct Lithuanian University Health Sciences period 2013 2016 year . 4 visit proceed study : screening visit 3 additional visit - inclusion study visit , visit 3 month visit 6 month . The screen visit ( 0 visit ) During screen visit woman question routine life medical history . They undergo routine general clinical gynecological examination : 1. height/weight ( BMI calculation ) hip/waist measurement ; 2. blood pressure ( BP ) measurement ant cardiac auscultation ( heart rate ( HR ) test ) ; 3. auscultation lung palpation abdomen ; 4. assessment possible vein varicose leg ; 5. bimanual gynecological examination ; 6. breast palpation ; 7. genital ultrasound examination ass possible anatomical anomaly ; 8. thyroid ultrasound examination . Women meet assessment criterion introduce The Informed Consent Form . Women sign The Informed Consent Form invite come 1 visit . 1. visit Women repeatedly undergo routine general examination ( BP , HR ) . Genital thyroid ultrasound perform . Visual method determine degree hirsutism , originally describe Ferriman Gallwey ( F-G ) , perform . The density terminal hair 9 different body site score 0 4 , total score calculate . In addition F-G scoring , height/weight &amp; hip/waist measurement , record . Hirsutism diagnose case F-G≥8 score . - The woman , present hormonal contraception use contraindication hormonal therapy , one two medicine register Lithuania administered׃ Daylette ( 20 microgram Ethinylestradiol 3 mg Drospirenone ) Lindynette ( 20 microgram Ethinylestradiol 75 microgram Gestoden ) . - The woman , present non-hormonal contraception use , recommend barrier copntraception use ( BCM ) , Natural family plan method ( NFPM ) . Women give fill six questionnaires׃ 1 . General questionnaire , develop author find sociodemographic status ; 2 . Anxiety Depression Scale ( HAD ) - determine level anxiety depression ; 3 . WHO-Five Wellbeing Index ( WHO- 5 ) - evaluate woman 's well ; 4 . Big Five- ass personality trait ; 5 . Female Sexual Function Index ( FSFI ) - find detail sexual life ; 6 . Dyadic Adjustment Scale ( DAD ) - ass compatibility sexual partner . Following blood test performed׃ 1 . Lipogram , glycemia ; 2 . Hormonal analysis radioimmunoassay method ׃ total testosterone ( T ) , free testosterone ( FT ) , sex hormone bind globulin ( SHBG ) , dehydroepiandrosterone sulphate ( DHEAs ) , thyrotropin hormone ( TSH ) , free thyroxine ( FT4 ) ; 3 . Blood coagulation test׃ clotting time accord Ovran , fibrinogen , activate partial thromboplastin time ( aPTT ) . 4 . Total blood picture test ; 5 . Androgen receptor ( AR ) polymorphism test . Patients invite come another visit 3 month . 2 visit Women , arrive 3 month , interwied change well-being potential side effect cause COCs . Women undergo routine general examination BP , HR , height/weight &amp; hip/waist measurement ) . Genital thyroid ultrasound perform . The sign hyperandrogenism assess use F-G scoring system . Women give fill six questionnaires׃ 1 . Anxiety Depression Scale ; 2 . WHO-Five Wellbeing Index ; 3 . Big Five ; 4 . Female Sexual Function Index ; 5 . Dyadic Adjustment Scale ; 6 . Satisfaction Questionnaire- assess side effect , cause use contraceptive method . Patients invite come another visit 6 month . 3 visit Women , arrive 6 month , interwied change well-being potential side effect cause COCs . Women undergo routine general examination BP , HR , height/weight &amp; hip/waist measurement ) . The sign hyperandrogenism assess use F-G scoring system . Women give fill six questionnaires׃ 1 . Anxiety Depression Scale ; 2 . WHO-Five Wellbeing Index ; 3 . Big Five ; 4 . Female Sexual Function Index ; 5 . Dyadic Adjustment Scale ; 6 . Satisfaction Questionnaire . Following blood test performed׃ 1 . Lipogram , glycemia ; 2 . Hormonal analysis radioimmunoassay method ׃ T , FT , SHBG , DHEAs , TSH , FT4 ; 3 . Blood coagulation tests׃ clotting time accord Ovran , fibrinogen , aPTT ; 4 . Total blood picture test . For use COCs patient consult gynecologist performing study .</detailed_description>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>1 . 18 40 year old woman apply obstetriciangynaecologist contraception use preventive health care give consent participate study ( sign The Informed Consent Form ) eligible participate study . It important note woman underlie medical condition ( chronic non infection disease , chronic acute infection disease ) . 2 . Not use hormonal contraception 6 month . 1 . Women apply obstetriciangynaecologist consultation gynaecological pathology . 2 . Women underlie medical condition ( chronic non infection disease , chronic acute infection disease ) . 3 . Women , plan get pregnant 12 month . 4 . Pregnant woman ( suspect confirm pregnancy ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Hyperandrogenism</keyword>
	<keyword>Female sexual function</keyword>
</DOC>